These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 25003359)

  • 81. Relative edema volume is a predictor of outcome in patients with hyperacute spontaneous intracerebral hemorrhage.
    Gebel JM; Jauch EC; Brott TG; Khoury J; Sauerbeck L; Salisbury S; Spilker J; Tomsick TA; Duldner J; Broderick JP
    Stroke; 2002 Nov; 33(11):2636-41. PubMed ID: 12411654
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Targeting the immune system in intracerebral hemorrhage.
    Sheth KN; Rosand J
    JAMA Neurol; 2014 Sep; 71(9):1083-4. PubMed ID: 25004375
    [No Abstract]   [Full Text] [Related]  

  • 83. [Fingolimod in the treatment of multiple sclerosis. Novelties presented at the annual congress of the American Academy of Neurology (Toronto, April 2010)].
    Rabasseda X
    Drugs Today (Barc); 2010 Jul; 46 Suppl D():1-14. PubMed ID: 20820453
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Initial lymphocyte count and low BMI may affect fingolimod-induced lymphopenia.
    Warnke C; Dehmel T; Ramanujam R; Holmen C; Nordin N; Wolfram K; Leussink VI; Hartung HP; Olsson T; Kieseier BC
    Neurology; 2014 Dec; 83(23):2153-7. PubMed ID: 25361781
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The effect on heart rate of combining single-dose fingolimod with steady-state atenolol or diltiazem in healthy subjects.
    Kovarik JM; Lu M; Riviere GJ; Barbet I; Maton S; Goldwater DR; Schmouder RL
    Eur J Clin Pharmacol; 2008 May; 64(5):457-63. PubMed ID: 18196225
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Cerebral Microbleeds and the Effect of Intensive Blood Pressure Reduction on Hematoma Expansion and Functional Outcomes: A Secondary Analysis of the ATACH-2 Randomized Clinical Trial.
    Shoamanesh A; Morotti A; Romero JM; Oliveira-Filho J; Schlunk F; Jessel MJ; Ayres AM; Vashkevich A; Schwab K; Afzal MR; Cassarly C; Martin RH; Qureshi AI; Greenberg SM; Rosand J; Goldstein JN;
    JAMA Neurol; 2018 Jul; 75(7):850-859. PubMed ID: 29710119
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Selective Sphingosine-1-Phosphate Receptor 1 Modulation Attenuates Experimental Intracerebral Hemorrhage.
    Sun N; Shen Y; Han W; Shi K; Wood K; Fu Y; Hao J; Liu Q; Sheth KN; Huang D; Shi FD
    Stroke; 2016 Jul; 47(7):1899-906. PubMed ID: 27174529
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial.
    Laroni A; Brogi D; Morra VB; Guidi L; Pozzilli C; Comi G; Lugaresi A; Turrini R; Raimondi D; Uccelli A; Mancardi GL;
    BMC Neurol; 2014 Apr; 14():65. PubMed ID: 24690227
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Effect of fingolimod (FTY720) on cerebral blood flow, platelet function and macular thickness in healthy volunteers.
    Ocwieja M; Meiser K; David OJ; Valencia J; Wagner F; Schreiber SJ; Pleyer U; Ziemer S; Schmouder R
    Br J Clin Pharmacol; 2014 Dec; 78(6):1354-65. PubMed ID: 24976291
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Cytotoxic Edema and Adverse Clinical Outcomes in Patients with Intracerebral Hemorrhage.
    Li N; Guo J; Kang K; Zhang J; Zhang Z; Liu L; Liu X; Du Y; Wang Y; Zhao X
    Neurocrit Care; 2023 Apr; 38(2):414-421. PubMed ID: 36180765
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Rate of Perihematomal Edema Expansion Predicts Outcome After Intracerebral Hemorrhage.
    Urday S; Beslow LA; Dai F; Zhang F; Battey TW; Vashkevich A; Ayres AM; Leasure AC; Selim MH; Simard JM; Rosand J; Kimberly WT; Sheth KN
    Crit Care Med; 2016 Apr; 44(4):790-7. PubMed ID: 26757167
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The real-life experience with cardiovascular complications in the first dose of fingolimod for multiple sclerosis.
    Fragoso YD; Arruda CC; Arruda WO; Brooks JB; Damasceno A; Damasceno CA; Finkelsztejn A; Finkelsztejn J; Gama PD; Giacomo MC; Gomes S; Goncalves MV; Matta AP; de Morais MM; Oliveira EM; Ribeiro Y; Sato HK; Tauil CB
    Arq Neuropsiquiatr; 2014 Sep; 72(9):712-4. PubMed ID: 25252236
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Early Perihematomal Edema Expansion: Definition, Significance, and Association with Outcomes after Intracerebral Hemorrhage.
    Lv XN; Li ZQ; Deng L; Yang WS; Li YL; Huang YJ; Shen YQ; Xie XF; Li XH; Wang ZJ; Zhang ZW; Lv FJ; Luo JB; Sun SJ; Xie P; Li Q
    Oxid Med Cell Longev; 2021; 2021():6249509. PubMed ID: 34552686
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Safety and efficacy of remote ischemic conditioning for the treatment of intracerebral hemorrhage: A proof-of-concept randomized controlled trial.
    Zhao W; Jiang F; Li S; Liu G; Wu C; Wang Y; Ren C; Zhang J; Gu F; Zhang Q; Gao X; Gao Z; Song H; Ma Q; Ding Y; Ji X;
    Int J Stroke; 2022 Apr; 17(4):425-433. PubMed ID: 33739197
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Intensive Blood Pressure Lowering in Patients with Moderate to Severe Grade Acute Cerebral Hemorrhage: Post Hoc Analysis of Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-2 Trial.
    Qureshi AI; Foster LD; Lobanova I; Huang W; Suarez JI
    Cerebrovasc Dis; 2020; 49(3):244-252. PubMed ID: 32585668
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Placebo-controlled study of the effects of fingolimod on cardiac rate and rhythm and pulmonary function in healthy volunteers.
    Schmouder R; Hariry S; David OJ
    Eur J Clin Pharmacol; 2012 Apr; 68(4):355-62. PubMed ID: 22071882
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Withdrawal of fingolimod treatment for relapsing-remitting multiple sclerosis: report of six cases.
    Hakiki B; Portaccio E; Giannini M; Razzolini L; Pastò L; Amato MP
    Mult Scler; 2012 Nov; 18(11):1636-9. PubMed ID: 22829326
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Early surgical treatment for supratentorial intracerebral hemorrhage: a randomized feasibility study.
    Zuccarello M; Brott T; Derex L; Kothari R; Sauerbeck L; Tew J; Van Loveren H; Yeh HS; Tomsick T; Pancioli A; Khoury J; Broderick J
    Stroke; 1999 Sep; 30(9):1833-9. PubMed ID: 10471432
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Pretreatment of Sulfonylureas Reducing Perihematomal Edema in Diabetic Patients With Basal Ganglia Hemorrhage: A Retrospective Case-Control Study.
    Jingjing Z; Jingjing Z; Bo H; Le W; Jingya W; Dong W; Fang Y; Wen J
    Front Neurol; 2021; 12():736383. PubMed ID: 34744976
    [No Abstract]   [Full Text] [Related]  

  • 100. [Cystoid macular oedema after fingolimod treatment in multiple sclerosis].
    Asensio-Sánchez VM; Trujillo-Guzmán L; Ramoa-Osorio R
    Arch Soc Esp Oftalmol; 2014 Mar; 89(3):104-6. PubMed ID: 24269406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.